• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

8例先天性肾性尿崩症患者的临床特征

Clinical characteristics of eight patients with congenital nephrogenic diabetes insipidus.

作者信息

Mizuno Haruo, Sugiyama Yukari, Ohro Yoichiro, Imamine Hiroki, Kobayashi Masanori, Sasaki Sei, Uchida Sinichi, Togari Hajime

机构信息

Department of Pediatrics, Neonatology and Congenital Disorders, Nagoya City University, Graduate School of Medical Sciences, Nagoya, Japon.

出版信息

Endocrine. 2004 Jun;24(1):55-9. doi: 10.1385/ENDO:24:1:055.

DOI:10.1385/ENDO:24:1:055
PMID:15249704
Abstract

Congenital nephrogenic diabetes insipidus (NDI) is characterized by the insensitivity of the distal nephron to arginine vasopressin. Clinical knowledge of this disease is based largely on case reports. For this study, we investigated the clinical findings of eight patients in terms of age at onset, age at diagnosis, main complaint, results of physical examination, the diagnosis, the effect of treatment, kidney function, and presence or absence of gene defects. The main complaints of all eight cases at initial examination were unknown fever, failure to thrive, and short stature. Polyuria and polydipsia are not always the chief complaints with congenital NDI. In one case, diabetes insipidus could be diagnosed based only on the results of a 5% hypertonic saline test. In six cases, we found abnormalities in the V2 receptor gene. Initially, trichlormethiazide therapy was shown to have a significant effect on polyuria; however, this effect decreased over time. In one patient with partial NDI, the addition of trichlormethiazide twice a day to 1-desamino-8-D-arginine vasopressin increased urine osmolality in the morning and caused nocturia to disappear. Results of 99mTc-diethylenetriamine pentaacetic acid kidney scintigraphy revealed a slight decrease in glomerular filtration rate in three patients. No patient experienced serious renal dysfunction.

摘要

先天性肾性尿崩症(NDI)的特征是远端肾单位对精氨酸加压素不敏感。关于这种疾病的临床知识很大程度上基于病例报告。在本研究中,我们从发病年龄、诊断年龄、主要症状、体格检查结果、诊断、治疗效果、肾功能以及是否存在基因缺陷等方面调查了8例患者的临床情况。所有8例患者初诊时的主要症状均为不明原因发热、生长发育迟缓及身材矮小。多尿和烦渴并非先天性NDI的总是主要症状。在1例患者中,仅根据5%高渗盐水试验结果即可诊断尿崩症。在6例患者中,我们发现V2受体基因存在异常。最初,氢氯噻嗪治疗对多尿显示出显著效果;然而,随着时间推移这种效果减弱。在1例部分性NDI患者中,每天两次将氢氯噻嗪添加到1-去氨基-8-D-精氨酸加压素中,可使晨尿渗透压升高并使夜尿消失。99mTc-二乙三胺五乙酸肾闪烁显像结果显示,3例患者的肾小球滤过率略有下降。没有患者出现严重肾功能障碍。

相似文献

1
Clinical characteristics of eight patients with congenital nephrogenic diabetes insipidus.8例先天性肾性尿崩症患者的临床特征
Endocrine. 2004 Jun;24(1):55-9. doi: 10.1385/ENDO:24:1:055.
2
Successful treatment of partial nephrogenic diabetes insipidus with thiazide and desmopressin.噻嗪类利尿剂与去氨加压素联合成功治疗部分性肾性尿崩症。
Horm Res. 2003;59(6):297-300. doi: 10.1159/000070629.
3
Nephrogenic diabetes insipidus persisting 57 months after cessation of lithium carbonate therapy: report of a case and review of the literature.碳酸锂治疗停止后持续57个月的肾性尿崩症:一例报告及文献复习
Endocr Pract. 2000 Jul-Aug;6(4):324-8. doi: 10.4158/EP.6.4.324.
4
[Congenital nephrogenic diabetes insipidus: a difficult diagnosis?].[先天性肾性尿崩症:诊断困难?]
Ned Tijdschr Geneeskd. 1997 Mar 29;141(13):609-12.
5
Novel AVPR2 mutations and clinical characteristics in 28 Chinese families with congenital nephrogenic diabetes insipidus.28 个中国先天性肾性尿崩症家庭的新型 AVPR2 突变与临床特征。
J Endocrinol Invest. 2021 Dec;44(12):2777-2783. doi: 10.1007/s40618-021-01607-3. Epub 2021 Jun 8.
6
Physiopathology and diagnosis of nephrogenic diabetes insipidus.肾源性尿崩症的病理生理学和诊断。
Ann Endocrinol (Paris). 2012 Apr;73(2):128-9. doi: 10.1016/j.ando.2012.03.032. Epub 2012 Apr 13.
7
Hyperuricemia as a clue for central diabetes insipidus (lack of V1 effect) in the differential diagnosis of polydipsia.高尿酸血症作为鉴别诊断烦渴时中枢性尿崩症(缺乏V1效应)的线索。
Am J Med. 1997 Nov;103(5):376-82. doi: 10.1016/s0002-9343(97)00165-4.
8
V2R mutations and nephrogenic diabetes insipidus.V2R 突变与肾性尿崩症。
Prog Mol Biol Transl Sci. 2009;89:15-29. doi: 10.1016/S1877-1173(09)89002-9. Epub 2009 Oct 7.
9
A novel mutation in the renal V2 receptor gene in a boy with trisomy 21.
Pediatr Nephrol. 2004 Jun;19(6):609-11. doi: 10.1007/s00467-004-1446-8. Epub 2004 Mar 30.
10
Nephrogenic Diabetes Insipidus.肾性尿崩症
Pediatr Clin North Am. 2019 Feb;66(1):227-234. doi: 10.1016/j.pcl.2018.09.006.

引用本文的文献

1
Hypertensive urgency in nephrogenic diabetes insipidus with concomitant Hinman syndrome.伴有欣曼综合征的肾性尿崩症中的高血压急症
BMJ Case Rep. 2019 Jul 27;12(7):e229095. doi: 10.1136/bcr-2018-229095.
2
Clinical overview of nephrogenic diabetes insipidus based on a nationwide survey in Japan.基于日本全国性调查的肾性尿崩症临床概述
Yonago Acta Med. 2014 Jun;57(2):85-91. Epub 2014 Jul 30.
3
Growth failure in an infant with congenital nephrogenic diabetes insipidus during sodium restriction.先天性肾性尿崩症婴儿在限钠期间生长发育迟缓。

本文引用的文献

1
Successful treatment of partial nephrogenic diabetes insipidus with thiazide and desmopressin.噻嗪类利尿剂与去氨加压素联合成功治疗部分性肾性尿崩症。
Horm Res. 2003;59(6):297-300. doi: 10.1159/000070629.
2
Three families with autosomal dominant nephrogenic diabetes insipidus caused by aquaporin-2 mutations in the C-terminus.三个因水通道蛋白-2 C末端突变导致常染色体显性遗传性肾源性尿崩症的家族。
Am J Hum Genet. 2001 Oct;69(4):738-48. doi: 10.1086/323643. Epub 2001 Aug 30.
3
The property of a novel v2 receptor mutant in a patient with nephrogenic diabetes insipidus.
Clin Pediatr Endocrinol. 2007;16(4):95-8. doi: 10.1297/cpe.16.95. Epub 2007 Nov 17.
4
Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment.肾源性尿崩症:对分子背景的基本认识及治疗的潜在疗法。
Endocr Rev. 2013 Apr;34(2):278-301. doi: 10.1210/er.2012-1044. Epub 2013 Jan 29.
5
Hereditary nephrogenic diabetes insipidus in Japanese patients: analysis of 78 families and report of 22 new mutations in AVPR2 and AQP2.日本遗传性肾性尿崩症患者:AVPR2 和 AQP2 中 78 个家系的分析及 22 个新突变的报告。
Clin Exp Nephrol. 2013 Jun;17(3):338-44. doi: 10.1007/s10157-012-0726-z. Epub 2012 Nov 14.
6
Mutations in the AVPR2, AVP-NPII, and AQP2 genes in Turkish patients with diabetes insipidus.土耳其尿崩症患者的 AVPR2、AVP-NPII 和 AQP2 基因突变。
Endocrine. 2012 Dec;42(3):664-9. doi: 10.1007/s12020-012-9704-1. Epub 2012 May 29.
7
Clinical and molecular analysis of a Chinese family with autosomal dominant neurohypophyseal diabetes insipidus associated with a novel missense mutation in the vasopressin-neurophysin II gene.常染色体显性遗传神经垂体性尿崩症一家系的临床和分子分析及其与加压素-神经垂体素 II 基因新错义突变的关系。
Endocrine. 2012 Aug;42(1):208-13. doi: 10.1007/s12020-012-9606-2. Epub 2012 Feb 4.
8
Familial forms of diabetes insipidus: clinical and molecular characteristics.家族性尿崩症:临床与分子特征。
Nat Rev Endocrinol. 2011 Jul 5;7(12):701-14. doi: 10.1038/nrendo.2011.100.
9
Nephrogenic diabetes insipidus: treat with caution.肾性尿崩症:谨慎治疗。
Pediatr Nephrol. 2009 Sep;24(9):1761-3. doi: 10.1007/s00467-009-1187-9. Epub 2009 Apr 17.
J Clin Endocrinol Metab. 2001 Jan;86(1):381-5. doi: 10.1210/jcem.86.1.7165.
4
A novel splicing mutation in the V2 vasopressin receptor.
Pediatr Nephrol. 2000 Nov;15(1-2):43-9. doi: 10.1007/s004670000431.
5
Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus.33种新型AVPR2突变报告及117个X连锁肾性尿崩症家系分析
J Am Soc Nephrol. 2000 Jun;11(6):1044-1054. doi: 10.1681/ASN.V1161044.
6
Nephrogenic diabetes insipidus: functional analysis of new AVPR2 mutations identified in Italian families.肾性尿崩症:对意大利家族中鉴定出的新型精氨酸加压素受体2(AVPR2)突变的功能分析
J Am Soc Nephrol. 2000 Jun;11(6):1033-1043. doi: 10.1681/ASN.V1161033.
7
Clinical presentation and follow-up of 30 patients with congenital nephrogenic diabetes insipidus.30例先天性肾性尿崩症患者的临床表现及随访
J Am Soc Nephrol. 1999 Sep;10(9):1958-64. doi: 10.1681/ASN.V1091958.
8
AVPR2 variants and V2 vasopressin receptor function in nephrogenic diabetes insipidus.肾性尿崩症中的精氨酸加压素受体2(AVPR2)变体与V2血管加压素受体功能
Kidney Int. 1998 Dec;54(6):1909-22. doi: 10.1046/j.1523-1755.1998.00214.x.
9
Hereditary nephrogenic diabetes insipidus and bilateral nonobstructive hydronephrosis.遗传性肾性尿崩症和双侧非梗阻性肾积水。
Nephron. 1993;65(3):346-9. doi: 10.1159/000187510.
10
Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine.血管加压素依赖的尿液浓缩对人肾水通道蛋白-2的需求。
Science. 1994 Apr 1;264(5155):92-5. doi: 10.1126/science.8140421.